PNPLA8 Antikörper (Middle Region)

Produktnummer ABIN2786886

Dieses Anti-PNPLA8-Antikörper ist ein Kaninchen Polyklonal-Antikörper zur Detektion von PNPLA8 in WB. Geeignet für Human, Maus, Ratte, Kaninchen, Rind (Kuh), Hund, Meerschweinchen, Pferd und Zebrafisch (Danio rerio). Dieses Primary Antibody wurde in 1 Publikation zitiert.

Kurzübersicht für PNPLA8 Antikörper (Middle Region) (ABIN2786886)

Target: PNPLA8 (Patatin-Like phospholipase Domain Containing 8 (PNPLA8))

Reaktivität: Human, Maus, Ratte, Kaninchen, Rind (Kuh), Hund, Meerschweinchen, Pferd, Zebrafisch (Danio rerio)

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser PNPLA8 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB)

Produktdetails anti-PNPLA8 Antikörper

Bindungsspezifität: Middle Region

Sequenz: IDNRTRALVQ ALRRTTDPKL CITRVEELTF HLLEFPEGKG VAVKERIIPY

Homologie: Cow: 100%, Dog: 100%, Guinea Pig: 100%, Horse: 100%, Human: 100%, Mouse: 100%, Rabbit: 100%, Rat: 100%, Zebrafish: 92%

Produktmerkmale: This is a rabbit polyclonal antibody against PNPLA8. It was validated on Western Blot using a cell lysate as a positive control.

Aufreinigung: Affinity Purified

Immunogen: The immunogen is a synthetic peptide directed towards the middle region of human PNPLA8

Anwendungsinformationen

Applikationshinweise: Optimal working dilutions should be determined experimentally by the investigator.

Kommentare:

Antigen size: 782 AA

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: Lot specific

Buffer: Liquid. Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 2 % sucrose.

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Handhabung: Avoid repeated freeze-thaw cycles.

Lagerung: -20 °C

Informationen zur Lagerung: For short term use, store at 2-8°C up to 1 week. For long term storage, store at -20°C in small aliquots to prevent freeze-thaw cycles.

Referenzen für anti-PNPLA8 Antikörper (ABIN2786886)

Ali, Kokotos, Magrioti, Bone, Mobley, Hancock, Ramanadham: "Characterization of FKGK18 as inhibitor of group VIA Ca2+-independent phospholipase A2 (iPLA2β): candidate drug for preventing beta-cell apoptosis and diabetes." in: PLoS ONE, Vol. 8, Issue 8, pp. e71748, (2013) (PubMed).

Details zu PNPLA8

Target: PNPLA8 (Patatin-Like phospholipase Domain Containing 8 (PNPLA8))

Andere Bezeichnung: PNPLA8

Hintergrund: Phospholipase A2 catalyzes cleavage of fatty acids from phospholipids, thereby regulating membrane physical properties and the release of lipid second messengers and growth factors. Phospholipase A2 activity also modulates cellular growth programs, inflam
Alias Symbols: IPLA2(GAMMA), IPLA2-2, IPLA2G
Protein Interaction Partner: UBC,
Protein Size: 782

Molekulargewicht: 88 kDa

Gen-ID: 50640

NCBI Accession: NM_015599, NP_056538

UniProt: Q9NP80